Biosynex SA (0DL) Price & Analysis

0DL Stock Chart & Stats

€0.81€0.01(1.00%)

At close: Oct 30 4:00 PM EDT

Day’s Range: EUR 0.81 - EUR 0.81
52-Week Range: EUR 0.46 - EUR 1.61
Previous Close: EUR 0.80
Volume: 0
Average Volume (3M): 119
Market Cap: EUR 15.21M
Enterprise Value: EUR 70.41T
Total Cash (Recent Filing): EUR 8.46M
Total Debt (Recent Filing): EUR 61.65M
Price to Earnings (P/E): ―
Beta: -0.28
Next Earnings: N/A
EPS Estimate: N/A
Next Dividend Ex-Date: N/A
Dividend Yield: N/A

Biosynex SA News

Biosynex Subsidiary Chembio Wins $5.7 Million BARDA Grant for Biothreat Diagnostic Panel

Biosynex SA ( ($FR:ALBIO) ) has provided an update. Chembio Diagnostic Systems, a wholly owned subsidiary of Biosynex, has been awarded $5.7 million in U.S. federal funding to support a

1w ago0DL ALBIO

Biosynex Narrows Losses, Exits Safeguard as Restructuring Takes Hold

Biosynex SA ( ($FR:ALBIO) ) just unveiled an announcement. Biosynex reported first-half 2026 revenue of €45.3 million, down 10.4% year on year, but delivered a sharply improved net result of

1w ago0DL ALBIO

Biosynex exits safeguard proceedings after court approves restructuring plan

An update from Biosynex SA ( ($FR:ALBIO) ) is now available. Biosynex SA has secured court approval of its safeguard plan from the Judicial Court of Strasbourg, formally ending the

2w ago0DL ALBIO

Biosynex Wins Creditor Backing for Safeguard Plan Ahead of Court Ruling

Biosynex SA ( ($FR:ALBIO) ) has provided an announcement. Biosynex SA has secured strong creditor support for its draft safeguard plan, with an 81.6% participation rate and 75.8% of votes

1M ago0DL ALBIO

Biosynex Creditors Vote on Safeguard Plan Restructuring €81.8m in Liabilities

Biosynex SA ( ($FR:ALBIO) ) has shared an announcement. Biosynex SA has entered safeguard proceedings in Strasbourg, aiming to optimize its financial structure and refocus on profitable, high-potential activities while

1M ago0DL ALBIO

Biosynex Co-Founder Thierry Paper Steps Down From Executive and Board Roles

Biosynex SA ( ($FR:ALBIO) ) has provided an announcement. Biosynex announced that co-founder Thierry Paper has resigned from his roles as Deputy Chief Executive Officer and Director effective 31 August

2M ago0DL ALBIO

Biosynex Reports Cyberattack With Limited Data Impact and No Operational Disruption

Biosynex SA ( ($FR:ALBIO) ) has shared an update. Biosynex SA announced that it was the victim of a cyberattack between July 31 and August 2, 2026, prompting immediate preventive

2M ago0DL ALBIO

Biosynex H1 Revenue Falls as Restructuring and Debt Safeguard Progress

Biosynex SA ( ($FR:ALBIO) ) just unveiled an announcement. Biosynex reported first-half 2026 revenue of €44.1M, a 13% year-on-year decline, as its Pharmacy, Diagnostic Europe and Diagnostic USA divisions all

3M ago0DL ALBIO

BIOSYNEX SA Announces Share and Voting Rights Update

Biosynex SA ( ($FR:ALBIO) ) has provided an update. BIOSYNEX SA announced the number of shares and voting rights as of February 28, 2025, with 18,748,031 shares and 22,531,235 voting

1y ago0DL ALBIO

Biosynex SA Secures 7.99 Million Euros in Capital Increase

Biosynex SA ( ($FR:ALBIO) ) has issued an update. Biosynex SA successfully completed a capital increase, securing gross proceeds of 7.99 million euros by issuing 7,987,161 new shares at a

1y ago0DL ALBIO

0DL FAQ

What was Biosynex SA’s price range in the past 12 months?

Biosynex SA lowest stock price was €0.46 and its highest was €1.61 in the past 12 months.

What is Biosynex SA’s market cap?

Biosynex SA’s market cap is €15.21M.

When is Biosynex SA’s upcoming earnings report date?

The company’s upcoming earnings report date is not yet available.

Is Biosynex SA overvalued?

Not enough analysts have published a price target to calculate whether the price is overvalued.

Does Biosynex SA pay dividends?

Biosynex SA does not currently pay dividends.

What is Biosynex SA’s EPS estimate?

Biosynex SA’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does Biosynex SA have?

Biosynex SA has 18,748,032 shares outstanding.

Which hedge fund is a major shareholder of Biosynex SA?

Currently, no hedge funds are holding shares in DE:0DL

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

Company Description

Biosynex SA

Biosynex S.A. specializes in the development, manufacture, and worldwide distribution of rapid diagnostic solutions. Their extensive product line includes a variety of quick diagnostic assays, immunoblots, molecular biology tools, and point-of-care devices. These offerings are vital for screening, diagnosis, and prevention across numerous medical fields, such as bacteriology, parasitology, mycology, virology, biochemistry, oncology, and women's health, alongside specific COVID-19 tests and related instruments. Additionally, Biosynex provides consumer products like self-testing kits, personal health monitoring equipment (including thermometers and blood pressure monitors), and a selection of oral care and medical aid supplies. The company serves a diverse client base, including biological and medical analysis laboratories, hospitals, pharmacies, and large retail outlets like hypermarkets and supermarkets. Founded in 1993, Biosynex S.A. is headquartered in Illkirch-Graffenstaden, France.

Technical Analysis

Overall Consensus

Indicator	Bullish	Neutral	Bearish
Overall Consensus	8	5	8
Technical Analysis	4	5	0
Moving Averages	4	0	8

Technical Analysis >

Similar Stocks

Stocks similar to DE:0DL
Company	Price & Change	Follow
FR:BIMbioMerieux
FR:ERFEurofins Scientific
FR:ALNOVNovacyt
FR:ALERSEurobio-Scientific SA
FR:ABLDABL Diagnostics SA

Compare DE:0DL Stocks >

Popular Stocks

Popular Stocks
Company	Price & Change	Follow
NVDANvidia
AAPLApple
MSFTMicrosoft

Biosynex SA stock analysis